These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 11976208
21. Estrogens as endogenous genotoxic agents--DNA adducts and mutations. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. J Natl Cancer Inst Monogr; 2000; (27):75-93. PubMed ID: 10963621 [Abstract] [Full Text] [Related]
22. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells. Singh S, Zahid M, Saeed M, Gaikwad NW, Meza JL, Cavalieri EL, Rogan EG, Chakravarti D. J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038 [Abstract] [Full Text] [Related]
23. Slow loss of deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and hexestrol-3',4'-quinone. Implications for mutagenic activity. Saeed M, Zahid M, Gunselman SJ, Rogan E, Cavalieri E. Steroids; 2005 Jan; 70(1):29-35. PubMed ID: 15610894 [Abstract] [Full Text] [Related]
28. Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease. Zahid M, Saeed M, Rogan EG, Cavalieri EL. Free Radic Biol Med; 2010 Jan 15; 48(2):318-24. PubMed ID: 19909805 [Abstract] [Full Text] [Related]
29. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J, Cavalieri E. Int J Cancer; 2007 Apr 15; 120(8):1821-4. PubMed ID: 17230531 [Abstract] [Full Text] [Related]
30. The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and N-acetylcysteine Are the Preventers. Cavalieri E, Rogan E. Int J Mol Sci; 2021 Jul 30; 22(15):. PubMed ID: 34361004 [Abstract] [Full Text] [Related]
31. Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells. Yang L, Zahid M, Liao Y, Rogan EG, Cavalieri EL, Davidson NE, Yager JD, Visvanathan K, Groopman JD, Kensler TW. Carcinogenesis; 2013 Nov 30; 34(11):2587-92. PubMed ID: 23843041 [Abstract] [Full Text] [Related]
33. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. Lu F, Zahid M, Saeed M, Cavalieri EL, Rogan EG. J Steroid Biochem Mol Biol; 2007 Nov 30; 105(1-5):150-8. PubMed ID: 17582757 [Abstract] [Full Text] [Related]
37. Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation. Zahid M, Saeed M, Lu F, Gaikwad N, Rogan E, Cavalieri E. Free Radic Biol Med; 2007 Dec 01; 43(11):1534-40. PubMed ID: 17964424 [Abstract] [Full Text] [Related]
38. Endogenous estrogens as carcinogens through metabolic activation. Yager JD. J Natl Cancer Inst Monogr; 2000 Dec 01; (27):67-73. PubMed ID: 10963620 [Abstract] [Full Text] [Related]
39. Novel biomarkers for risk of prostate cancer: results from a case-control study. Yang L, Gaikwad NW, Meza J, Cavalieri EL, Muti P, Trock B, Rogan EG. Prostate; 2009 Jan 01; 69(1):41-8. PubMed ID: 18816637 [Abstract] [Full Text] [Related]
40. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Chem Res Toxicol; 1996 Jan 01; 9(5):851-9. PubMed ID: 8828920 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]